Bausch Health Companies Inc.

NYSE:BHC Stok Raporu

Piyasa değeri: US$3.1b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Bausch Health Companies Yönetim

Yönetim kriter kontrolleri 2/4

Bausch Health Companies' CEO'su Tom Appio, May2022 tarihinde atandı, in görev süresi 2.42 yıldır. in toplam yıllık tazminatı $ 15.88M olup, şirket hissesi ve opsiyonları dahil olmak üzere 7.4% maaş ve 92.6% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.12% ine doğrudan sahiptir ve bu hisseler $ 3.56M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.4 yıl ve 8.3 yıldır.

Anahtar bilgiler

Tom Appio

İcra Kurulu Başkanı

US$15.9m

Toplam tazminat

CEO maaş yüzdesi7.4%
CEO görev süresi2.4yrs
CEO sahipliği0.1%
Yönetim ortalama görev süresi2.4yrs
Yönetim Kurulu ortalama görev süresi8.3yrs

Son yönetim güncellemeleri

Recent updates

Sale Rumors Lift Both Bausch + Lomb And Parent Bausch Health - A Breakthrough Is Likely

Sep 19

Investors Don't See Light At End Of Bausch Health Companies Inc.'s (NYSE:BHC) Tunnel And Push Stock Down 28%

Aug 06
Investors Don't See Light At End Of Bausch Health Companies Inc.'s (NYSE:BHC) Tunnel And Push Stock Down 28%

2 Red Alerts On Bausch Health Companies

Jul 25

The Market Doesn't Like What It Sees From Bausch Health Companies Inc.'s (NYSE:BHC) Revenues Yet As Shares Tumble 25%

May 21
The Market Doesn't Like What It Sees From Bausch Health Companies Inc.'s (NYSE:BHC) Revenues Yet As Shares Tumble 25%

Why Bausch Health Stock Plunged After Posting First-Quarter 2024 Results

May 07

Bausch Health: A Timely Divestiture Is The Key To An Higher Valuation

Feb 24

Bausch Health: $20bn Debt Is A Mighty Elephant In The Room

Nov 30

Does Bausch Health Companies (NYSE:BHC) Have A Healthy Balance Sheet?

Nov 01
Does Bausch Health Companies (NYSE:BHC) Have A Healthy Balance Sheet?

Bausch Health's Debt Dilemma: Strategic Decisions And Financial Metrics

Sep 24

Is Bausch Health Companies (NYSE:BHC) A Risky Investment?

Jul 24
Is Bausch Health Companies (NYSE:BHC) A Risky Investment?

Bausch + Lomb: $2.5bn M&A Deal Shows It Hasn't Learned From Parent's Mistakes

Jul 06

What To Do After Bausch Health Stock Plunged By Nearly 9% Again

Jun 07

Bausch Health Companies (NYSE:BHC) Has No Shortage Of Debt

Apr 18
Bausch Health Companies (NYSE:BHC) Has No Shortage Of Debt

Bausch Health: A Basket Case Of A Business Only A Hedge Fund Can Bail Out

Dec 30

Bausch Health acne lotion Arazlo available in Canada under public drug plans

Dec 22

Bausch Health: Things To Consider Before Investing

Dec 11

Bausch Health Companies (NYSE:BHC) Strong Profits May Be Masking Some Underlying Issues

Nov 10
Bausch Health Companies (NYSE:BHC) Strong Profits May Be Masking Some Underlying Issues

Bausch Health Companies Q3 2022 Earnings Preview

Nov 02

Bausch Health: Long-Term Need To Place Stops For Protection

Sep 28

Bausch Health Companies: Equity Stub Would Benefit From Ambitious Spinoff

Sep 21

CEO Tazminat Analizi

Tom Appio'un ücretlendirmesi Bausch Health Companies'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$471m

Mar 31 2024n/an/a

-US$455m

Dec 31 2023US$16mUS$1m

-US$592m

Sep 30 2023n/an/a

-US$963m

Jun 30 2023n/an/a

-US$186m

Mar 31 2023n/an/a

-US$357m

Dec 31 2022US$13mUS$1m

-US$225m

Sep 30 2022n/an/a

US$254m

Jun 30 2022n/an/a

US$43m

Mar 31 2022n/an/a

-US$407m

Dec 31 2021US$10mUS$854k

-US$948m

Sep 30 2021n/an/a

-US$1b

Jun 30 2021n/an/a

-US$1b

Mar 31 2021n/an/a

-US$1b

Dec 31 2020US$4mUS$775k

-US$560m

Sep 30 2020n/an/a

-US$2b

Jun 30 2020n/an/a

-US$2b

Mar 31 2020n/an/a

-US$2b

Dec 31 2019US$4mUS$769k

-US$2b

Sep 30 2019n/an/a

-US$616m

Jun 30 2019n/an/a

-US$917m

Mar 31 2019n/an/a

-US$2b

Dec 31 2018US$4mUS$730k

-US$4b

Sep 30 2018n/an/a

-US$3b

Jun 30 2018n/an/a

-US$2b

Mar 31 2018n/an/a

-US$805m

Dec 31 2017US$3mUS$650k

US$2b

Tazminat ve Piyasa: Tom 'nin toplam tazminatı ($USD 15.88M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 6.79M ).

Tazminat ve Kazançlar: Tom şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Tom Appio (62 yo)

2.4yrs

Görev süresi

US$15,878,578

Tazminat

Mr. Thomas J. Appio, also known as Tom, serves as the Chief Executive Officer & Director at Bausch Health Companies Inc. and served as Chief Executive Officer of Pharma Business and served as President & C...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Thomas Appio
CEO & Director2.4yrsUS$15.88m0.12%
$ 3.6m
Seana Carson
Executive VP & General Counsel2.4yrsUS$3.16m0.035%
$ 1.1m
Jean-Jacques Charhon
Chief Financial Officerless than a yearVeri yokVeri yok
Mirza Dautbegovic
Executive VP & COO2.8yrsVeri yok0.035%
$ 1.1m
Kathleen Fitzpatrick
Executive VP and Chief HR & Communications Officer2.8yrsVeri yokVeri yok
Tage Ramakrishna
Chief Medical Officer and President of R&Dno dataVeri yokVeri yok
Jeff Hartness
Executive VP of Market Access4.3yrsVeri yokVeri yok
Cees Heiman
Senior Vice President of Europe & Canada2.8yrsVeri yokVeri yok
Donald Pearl
Senior Vice President of Ortho Dermatologicsno dataVeri yokVeri yok
Jiny Kim
Senior Vice President of Solta Medical1.8yrsVeri yokVeri yok
Aimee Lenar
Executive Vice President of US Pharmaless than a yearVeri yokVeri yok
William Woodfield
Senior VP & Treasurerno dataVeri yokVeri yok

2.4yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim: BHC 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.4 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Thomas Appio
CEO & Director2.4yrsUS$15.88m0.12%
$ 3.6m
John Paulson
Independent Chairman2.3yrsUS$812.50k0.000060%
$ 1.8k
Robert Power
Independent Director16.2yrsUS$389.55k0.0018%
$ 55.0k
H. Fibiger
Chairman of External Advisory Boardno dataUS$2.00mVeri yok
Sarah Kavanagh
Independent Director8.3yrsUS$718.28k0%
$ 0
Robert Lenox
Member of the External Advisory Board15.6yrsVeri yokVeri yok
Kathleen Clarence-Smith
Member of the External Advisory Board15.6yrsVeri yokVeri yok
Karoly Nikolich
Member of the External Advisory Board15.6yrsVeri yokVeri yok
Brett Icahn
Independent Director3.6yrsUS$691.72k0.00020%
$ 6.1k
Amy Wechsler
Independent Director8.3yrsUS$377.50k0.011%
$ 350.6k
Steven Miller
Independent Director3.6yrsUS$381.31k0.031%
$ 939.2k
Christian Garcia
Independent Directorless than a yearVeri yokVeri yok

8.3yrs

Ortalama Görev Süresi

67yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: BHC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.3 yıldır).